Monitoring and evaluation
High-grade cervical lesions
- Among all diagnostic procedures, 21% are diagnosed with HSIL+, while this is the case with 70% of therapeutic procedures.
- Around 90% of women with HSIL+ biopsy have another invasive procedure (mainly therapeutic) preformed in one year period. HSIL+ is detected in almost 90% of follow-up therapeutic procedures.
- On average, 1,600 women per year were newly diagnosed with CIN2+ in the last years, 1,500 in the target age group 20–64 (excluding the pandemic).
Table: Number of newly diagnosed CIN2+ cases by age group*
*A newly diagnosed CIN2+ case in this table is defined as histopathologicaly confirmed CIN2+, followin a diagnostic or therapeutic invasive procedure (hysterectomies excluded), in a patient without such diagnosis in the past 3 years.
Jerman T, Ivanuš U, Florjančič M. ZORA Programme Monitoring and Evaluation. ZORA: Slovenian National Cervical Cancer Screening Programme and Registry. 2023. https://zora.onko-i.si/en/monitoring-and-evaluation/.